Skip to main content

Table 3 Clinical outcomes

From: Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis

Clinical Outcome Results
Number of exacerbations, median (range) 2 (0,13)
Age at study completion in years, median (range) 3.7 (2.2–7.1)
Brasfield chest x-ray scores, enrollment 21.5 (18.0,25.0)
Brasfield chest x-ray scores, study completion 21.0 (17.0,24.0)
Change in chest x-ray scores, n = 25, median (range) −0.5 (−3.0, 4.0)*
Culture results, n = subjects with positive culture at any time over two-year study period, (%)
Staphylococcus aureus 26 (87%)
Pseudomonas aeruginosa 4 (13%)
Haemophilus influenzae 29 (97%)
Stenotrophomonas maltophilia 4 (13%)
PEx Culture results, n = positive culture during PEx, (% of PEx) [# subjects with positive culture]
Staphyloccus aureus 37 (39%) [18]
Pseudomonas aeruginosa 2 (2%) [2]
Haemophilus influenzae 27 (28%) [15]
Stenotrophomonas maltophilia 4 (4%) [3]
Change in weight z-score, n = 28, median (range) 0.39 (−2.00, 1.61) *
FEV1 percent predicted at 7 years, n = 23, median (range) 104 (89–138)
  1. *signed rank test p-value <0.05